Pessac Cedex

France

55 total trials 29 recruiting

Filter these 55 trials by phase, condition, sponsor and more.

Open in Search →

Phase III randomized trial of atezolizumab in elderly patients with advanced Non-Small-Cell Lung Cancer and receiving monthly carboplatin wi … Ended recruitment

2024-515946-17-00 5 2019-07-22 Non Small Cell Lung Cancer
IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting Ended recruitment

2024-517489-41-00 5 2017-03-27 High-risk stage III colon cancer
A randomized, open-label, controlled phase III trial comparing the pembrolizumab platinum based chemotherapy combination with pembrolizumab … Ended

2024-513697-22-00 5 2024-11-07 non-small-cell lung cancer
Tepotinib plus osimertinib in osimertinib-relapsed MET amplified NSCLC Ended

2024-512005-87-00 4 2019-11-07 Lung Cancer
PROLONGSTEM is a long term follow-up study of all the patients who have received at least one infusion of HepaStem Ended

2022-500251-22-00 4 2018-04-12 This study will include all patients having received at least one infu
A phase I/II trial of Obinutuzumab, ABT-199 (GDC-0199) plus Ibrutinib in Relapsed / Refractory Mantle Cell Lymphoma patients (OAsIs) Ended

2024-516750-21-00 9 2015-10-14 Patients with relapsed / refractory Mantle Cell Lymphoma
PRODIGE 111 – DOMZIGAST A randomized phase II study evaluating FOLFIRI vs FOLFIRI plus Domvanalimab (anti-TIGIT) and Zimberelimab (anti-PD1) … Ended

2024-519258-35-00 4 stomach cancer

Showing 49–55 of 55 trials